ArticleMolecular pharmaceutics2026
Hotspot Interactions between Two Fab Molecules in Molecular Dynamics Simulations Improve Predictive Models of Aggregation Kinetics.
Article in Molecular pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein-protein interactions (PPIs) are fundamental to numerous biological processes, and the identification of interaction hotspots is essential for understanding the mechanisms of protein aggregation and informing protein engineering efforts. Although various algorithms have been developed to predict hotspot regions for protein-protein interactions, little research has focused on understanding the relative roles of these largely protein surface-based interactions and the interactions between cross-β sheet-forming aggregation-prone regions (APRs) that are largely buried within proteins. This study uses all-atom molecular dynamics (MD) simulations to investigate the interactions between two Fab antibody fragments, focusing on the identification and characterization of the key interaction sites. Through frequency contact map analysis and principal component analysis, we identified specific residues that consistently formed stable contacts, distinguishing them from transient random interactions. Our findings revealed that while numerous contact points occurred throughout the simulations, relatively few sites acted as persistent hotspots based on the duration of their contacts. Comparison to single Fab simulations highlighted the influence of interfragment interactions on conformational dynamics. Inclusion of solvent accessibility for two surface hotspots, alongside one predicted APR, significantly improved models for predicting aggregation kinetics over 49 formulation conditions. The molecular-level insights gained will be important for guiding protein engineering strategies aimed at modulating these interactions to enhance product stability and retain therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.